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Agonist MHC-peptide complexes in the immunolog-
ical synapse (IS) signal through T cell receptor (TCR)
microclusters (MCs) that converge into a central
supramolecular activation cluster (cSMAC). The
determinants and function of the cSMAC remain
unknown. We demonstrate an essential role for ubiq-
uitin (Ub) and TSG101, but less so for HRS, in signal
processing events at the cSMAC. Using siRNA in
primary T cells, we show that Ub recognition by
TSG101 is required for cSMAC formation, TCR MC
signal termination, TCR downregulation, and segre-
gation of TCR-MHC-peptide from PKC-q-enriched
signaling complexes. Weak agonist MHC-peptide
induced CD80-dependent TCRMCs that dissociated
in the center of the IS without recruiting TSG101.
These results support TSG101-dependent recogni-
tion of CD80-independent TCR MCs as a molecular
checkpoint for TCR downregulation.
INTRODUCTION
Complex signal integration in cells involves responses to diverse
stimuli that often utilize overlapping signal transduction machin-
ery. Appropriate responses to such stimuli may benefit from
spatial segregation of ligand-receptor interactions. In T cells,
immunological synapses (ISs) are specialized cell-cell junctions
that combine cell polarization and positional stability with spatial
segregation of interacting elements (Dustin, 2002; Dustin et al.,
1998; Monks et al., 1998). IS formation is critical for signal inte-
gration, as well as coordination of migration, directed secretion,
asymmetric cell division, and differentiation (Davis et al., 2007;
Dustin, 2008; Huppa and Davis, 2003; Krogsgaard et al., 2003).
In CD4+ T cells, the IS is composed of three primary subdomains:
a central supramolecular activation cluster (cSMAC) rich in prox-
imal signaling components such as T cell receptor (TCR)-major
histocompatibility complex (MHC)-peptide and PKC-q kinase,
a peripheral supramolecular activation cluster (pSMAC) domi-
nated by intercellular adhesion molecule-1 (ICAM-1)-lympho-
cyte function associated-1 (LFA-1) interactions, and a distalsupramolecular activation cluster (dSMAC) rich in dynamic actin
(Grakoui et al., 1999; Monks et al., 1998). The cSMAC is gener-
ated and maintained by microclusters (MCs) of 10–20 TCRs
that continuously form in an actin-dependent manner in the
dSMAC but that become actin independent as they translocate
to the IS center and fuse to form the cSMAC (Krummel et al.,
2000; Varma et al., 2006; Yokosuka et al., 2005). TCR MCs are
the sites of signal initiation based on recruitment and phosphor-
ylation of the signaling molecules Lck, ZAP-70, and LAT, as well
as SLP-76 and Grb-2 recruitment (Bunnell et al., 2002; Campi
et al., 2005; Huse et al., 2007; Yokosuka et al., 2005). In contrast,
the cSMAC has 1/20 amount of tyrosine phosphorylation
compared with MCs and cannot independently sustain Ca2+
signaling (Campi et al., 2005; Varma et al., 2006). The molecular
basis of signaling differences between MCs and the cSMAC is
unknown.
Ligand-mediated TCR downregulation occurs via routing of
internalized receptors to lysosomes (Valitutti et al., 1997), and
enrichment of the cSMAC in multivesicular body (MVB) markers
suggests a role for receptor degradation at the cSMAC (Varma
et al., 2006). However, not all ligands induce cSMAC formation,
and it has recently been proposed that avoidance of cSMAC
formation and TCR downregulation may underlie the elevated
stimulatory potency of certain weak agonist ligands (Cemerski
et al., 2007). TCR degradation may occur via ubiquitin (Ub)
recognition based on involvement of ubiquitin ligases such as
Cbl-b (Naramura et al., 2002). Degradation of ubiquitinated
substrates via MVBs is a stepwise process coordinated by
multiple family members of the endosomal sorting complex
required for transport (ESCRT) (Williams and Urbe´, 2007). There
are four ESCRT complexes (0, I, II, and III) with unique roles in
signal termination and receptor degradation of epidermal growth
factor receptor (EGFR). ESCRT-0 and -I directly recognize Ub
(Williams and Urbe´, 2007). ESCRT-0 can also associate with
ubiquitinated cargo through the Ub interaction motif (UIM) of
hepatocyte growth factor-regulated tyrosine kinase substrate
(HRS) (Bache et al., 2003b; Hirano et al., 2006) in parallel with
inositol-3-phosphate bearing lipids present in endosomes (Rai-
borg et al., 2001). ESCRT-I recognizes Ub through the ubiquitin
E3 variant (UEV) domain of tumor suppressor gene 101 (TSG101)
and is required for sorting of EGFR into MVBs (Pornillos et al.,
2002; Sundquist et al., 2004; Teo et al., 2004). In the absence
of TSG101, both MVB formation and sorting of proteins into
MVBs is inhibited, resulting instead in persistent EGFR signalingImmunity 32, 531–540, April 23, 2010 ª2010 Elsevier Inc. 531
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TSG101 in the Immunological Synapse(Bache et al., 2006; Doyotte et al., 2005). The specific role of
ESCRT complexes in TCR downregulation has not been deter-
mined.
Unresolved roles for the cSMAC in promoting proximal
signaling still exist, particularly with respect to PKCq, whose
enchrichment at the cSMAC has been described (Monks et al.,
1998; Monks et al., 1997). Activated PKC-q leads to downstream
activation of NF-kB and AP-1 transcription factors (Isakov and
Altman, 2002; Sun et al., 2000). CD28 is dispensable for PKC-q
recruitment to the IS, but is critical for its concentration in the
cSMAC (Huang et al., 2002). Recent reports have suggested
discrete sites of CD28, PKCq, and TCR enrichment within the
IS (Sims et al., 2007; Tseng et al., 2008; Yokosuka et al., 2008),
but the molecular basis for this segregation is as yet unclear.
Understanding mechanisms of segregation may provide insight
into how cells simultaneously process multiple signals.
To address the role of Ub and ESCRT-mediated Ub recogni-
tion in cSMAC formation and function, we have applied siRNA-
mediated suppression and high-resolution fluorescence micros-
copy of IS formed between primary T cells and supported
bilayers. We determined that Ub was required for cSMAC forma-
tion in the IS in response to agonistMHC-peptide complexes. Ub
recognition by ESCRT-I component TSG101, but not ESCRT-
0 component HRS, was required for cSMAC formation, TCR
MC signal termination, and segregation of TCR-agonist MHCp
complexes from PKC-q-enriched domains within an outer
cSMAC subdomain. We also demonstrated that TSG101 was
rapidly recruited to the plasma membrane after T cell activation
by fluorescence resonance energy transfer. Finally, signaling
MCs formed in response to weak agonist ligands remained actin
dependent and dissipated at the cSMAC-pSMAC boundary
without recruiting ESCRT-I complexes. The IS thus engages in
a conditional utilization of ESCRT-I and spatially defined check-
points to regulate T cell signaling and downregulation.
RESULTS
Ubiquitination Is Required for cSMAC Formation
Prior observations that MVBs are enriched at the cSMAC led us
to investigate whether ubiquitination is involved in IS patterning
(Varma et al., 2006). Treatment of cells with MG132 inhibits the
proteosome, resulting in accumulation of poly-ubiquitinated
substrates and depletion of the free ubiquitin pool (Melikova
et al., 2006). We therefore incubated MG132-treated AND
TCR transgenic (Tg) T cells on supported planar bilayers pre-
senting I-Ek-MCC + ICAM-1. Control treated T cells formed
TCRMCs, which accumulated in the cSMAC in response to bila-
yers presenting agonist MHC-peptide (Figure 1A; Figure S1A
and Movie S1 available online). In contrast, we found that
MG132-treated T cells were able to efficiently form TCR MCs,
but were unable to translocate MCs from the site of formation
to the IS center. The amount of TCR accumulating at the inter-
face was increased significantly in the MG132-treated cells (Fig-
ure 1B). Furthermore, MG132 treatment significantly impeded
termination of TCR signals, given that phosphorylation of
peripherally accumulated TCR MCs was 5- to 10-fold higher in
MG132 treated T cell IS as compared to control T cell IS (Figures
1A and 1B). Although MG132 treatment may have a number of
additional effects, these results suggest that ubiqutination is532 Immunity 32, 531–540, April 23, 2010 ª2010 Elsevier Inc.required for cSMAC formation and encouraged us to further
pursue this line of experimentation.
TSG101 Is Required for cSMAC Formation and MC
Dephosphorylation
The suggested role for ubiquitination in cSMAC formation led us
to investigate the role of ubiquitin recognizing ESCRT complex
components in regulating TCR signaling within the IS. We chose
to target HRS and TSG101, the respective critical components of
the ESCRT-0 and ESCRT-I complexes with established ubiquitin
binding (Figure 1C) (Williams and Urbe´, 2007). We developed
a procedure to efficiently suppress expression of HRS or
TSG101 in 100% of activated AND TCR transgenic (Tg) T cells,
by nucleofection of either specific siRNA duplexes or scrambled
versions of the same sequence as controls. We were able to
reduce HRS and TSG101 expression more than 90% during
primary expansion of AND TCR Tg T cells (Figure 1D).
In EGFR systems, ESCRT-0 is initially recruited to ubiquiti-
nated cargo within clathrin-coated pits and is required for effi-
cient receptor degradation (Bache et al., 2003a; Bilodeau
et al., 2003; Katzmann et al., 2003). However, HRS knockdown
(KD) T cells formed a cSMAC containing dephosphorylated
TCR (Figures 1E and 1F). In addition, T cells transfected with
GFP-tagged clathrin light chain showed no colocalization of
clathrin-coated pits with TCR MCs in the IS (Figure S1B and
Movie S2). However, clathrin-coated pits were present in distinct
puncta emerging in the IS periphery and accumulated in the IS
center (Figure S1B and Movie S2). Furthermore, HRS KD re-
sulted in accumulation of phosphotyrosine in the IS periphery
that did not colocalize with TCR (Figures 1E and 1F). This leaves
open the possibility that clathrin-HRS might be involved in regu-
lation of downstream signaling complexes that are known to
dissociate from TCR MCs and signal independently (Bunnell
et al., 2002); however, because this phenotype is distinct from
that of MG132 treatment, we did not pursue this further here.
In contrast to HRS, TSG101 KD generated a phenotype more
similar to that of MG132 treatment. Control siRNA-treated cells
formed TCRMCs, which accumulated in the cSMAC in response
to bilayers presenting agonist MHCp. In contrast, TCR MCs
failed to translocate to the cSMAC and instead accumulated
more peripherally in TSG101 KD T cells (Figure 1G, Figures
S1C and S1D, and Movie S3). TSG101 KD resulted in accumula-
tion of phosphorylated TCR MCs in quantities and distribution
that were similar to MG132-treated T cell IS (Figures 1G and
1H and Figures S1C and S1D), suggesting that TSG101 translo-
cates ubiquitinated TCR MCs to the cSMAC for dephosphoryla-
tion and degradation. The elevated antiphosphotyrosine inten-
sity in TSG101 KD ISs did not correlate directly with the TCR
intensity in MCs, but all visible TCR MCs were intensely phos-
photyrosine positive, except in rare cases in which TCR MCs
penetrated into the IS center. A proportion of the elevated phos-
photyrosine signal in TSG101 KD ISs did not colocalize with
TCR. This may be due to phosphorylation of small clusters of
TCR that are below the limit of detection. Alternatively, they
may represent other surface proteins, such as LAT and associ-
ated proteins that are known to cluster independently after
TCR signaling (Balagopalan et al., 2007). The accumulation of
large TCR MCs in the periphery of TSG101 KD continued to
engage agonist MHCp (Figure S1E) and resulted in slightly
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Figure 1. TSG101 Is Required for Central
TCR Accumulation and Dephosphorylation
(A and B) AND T cells were pretreated with DMSO
(vehicle) or the proteasomal inhibitor MG132 to
deplete cells of free ubiquitin. They were then incu-
bated on glass-supported planar bilayers contain-
ing 10 molec/mm2 I-Ek-MCC and 200 molec/mm2
ICAM-1 for 30 min at 37C, fixed, and stained for
TCR and phosphoytrosine (pY). In (B), bar graphs
depict quantification in arbitrary units (AUs) of
mean fluorescence at cell contact interfaces and
represent >100 cells across three experiments.
Standard errors are indicated.
(C) A model for ESCRT recruitment to ubiquiti-
nated substrates. HRS, the critical component of
ESCRT-0, binds ubiquitin through its UIM domain
but requires recruitment to PI-3-P-rich endosomes
through its FYVE domain. TSG101, the critical
component of ESCRT-I, binds ubiquitin through
its UEV domain.
(D) Cell lysates of 106 control TSG101 knockdown
(KD) and HRS KD T cells were separated by
SDS-PAGE and blotted for TSG101 and HRS.
Anti-alpha actin was used as a loading control.
(E and F) Control and HRS KD T cells were incu-
bated on glass-supported planar bilayers contain-
ing 10 molec/mm2 I-Ek-MCC and 200 molec/mm2
ICAM-1 for 30 min at 37C, fixed, and stained for
TCR and pY. In (F), bar graphs depict quantifica-
tion in arbitrary units (AU) of mean fluorescence
at cell contact interfaces, and represent >100 cells
across three experiments. Standard errors are
indicated.
(G and H) Control and TSG101 KD T cells were
incubated on glass-supported planar bilayers con-
taining 2molec/mm2 I-Ek-MCC and 200molec/mm2
ICAM-1 for 30 min at 37C, fixed, and stained for
TCR and pY. In (H), bar graphs depict quantifica-
tion in arbitrary units (AU) of mean fluorescence
at cell contact interfaces, and represent >100 cells
across three experiments. Standard errors are
indicated.
Immunity
TSG101 in the Immunological Synapsereduced LFA-1-ICAM-1 accumulation in the pSMAC, presum-
ably due to competitionwith the TCRMCs for space (Figure S1F).
The similarity in TCR location and colocalized phosphorylation
between the MG132 treatment and TSG101 KD led us to
further characterize TSG101’s role in IS formation and signal
processing.
In order to establish whether TSG101 was positioned to
play direct roles in IS patterning, we investigated the distribution
of TSG101 within T cells forming ISs. We found that both endog-
enous and recombinant fluorescent TSG101 were strongly re-
cruited to the cSMAC in response to agonist pMHC engagement
on supported planar bilayers (Figure S2).
TSG101 Is Required for cSMAC Formation
and Function in T-B Cell Conjugates
It remained possible, although unlikely, that our findings using
supported planar bilayers did not faithfully recapitulate IS forma-
tion and hence TSG101 function in cell-cell interfaces. To rule
out this possibility, we imaged control and TSG101 KD T cellsforming ISs with primary B cells by confocal microscopy.
Reconstructed T-B cell interfaces displayed comparable periph-
eral TCR accumulation and elevated phosphotyrosine after
TSG101 KD to those observed on bilayers (Figures 2A–2C).
Consistent with our imaging results, flow cytometry analysis of
intact or permeabilized T-B cell conjugates demonstrated a
significant defect in antigen-induced TCR surface downregula-
tion and degradation, respectively, in the absence of TSG101
(Figure 2D).
We then investigated whether the recruitment of TSG101 to
the IS seen in T cells incubated on supported planar bilayers
was recapitulated in a cell-cell system. In particular, we
wondered whether T cell activation resulted in recruitment of
TSG101 to membrane compartments, as would be required in
order to execute sorting processes within the IS. We therefore
evaluated activation-induced recruitment of TSG101 to T cell
membranes by fluorescence resonance energy transfer (FRET)
(Wouters et al., 1998). Efficient FRET between membranes and
associated signaling proteins has been reported by donorImmunity 32, 531–540, April 23, 2010 ª2010 Elsevier Inc. 533
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Figure 2. TSG101 Controls Central TCR
Accumulation and Dephosphorylation in T
Cell-B Cell Conjugates
(A–C) Control and TSG101 KD T cells mixed with
MCC-pulsed activated B cells at a 1:2 ratio, and
brought into contact by brief centrifugation. After
incubation at 37C for 30 min, cells were fixed,
stained for TCR and pY, and placed on clean
coverslips for confocal microscopy. Representa-
tive (A) images and (B) dot plots demonstrate
distribution and quantification of TCR and phos-
photyrosine (pY) in Control and TSG101 KD
synapses. For en face synapse reconstructions
(C), z-stacks of appropriately oriented cell conju-
gates were collected at 200 nm steps to a distance
of 8 mm from the coverslip surface.
(D) Control or TSG101 KD T cells were incubated
with A20 B cells expressing I-Ek and loaded with
either 10 mM or 100 mM MCC. After 30 min, they
were cooled to 4C and either stained directly for
surface TCR levels or fixed with 2% PFA, permea-
bilized with 90% methanol, and stained for total
TCR levels with antibodies against the AND TCR
Vb3 region. TCR levels were assessed by flow
cytometry. Values are reported as a percent of
TCR on T cells in culture with unloaded A20 cells.
Standard errors shown are based on 100 cells
from two or more experiments.
(E) TSG101-GFP expressing AND T cells were
labeled briefly with CM-DiI and incubated either
alone or mixed with MCC-pulsed activated B cells
at a 1:2 ratio and brought into contact by brief
centrifugation. After incubation at 37C for
30 min, cells were fixed and placed on clean
coverslips for confocal microscopy. Cells were
imaged for GFP and DiI fluorescence prior to and
after photobleaching of DiI (Pre- and Post-bleach).
D1 and D2 denote donor (GFP) fluorescence pre-
and post-bleach of DiI. D2-D1 is a difference
image, and D2-D1/D2 is the FRET image. Both
are depicted in pseudo-color (see color key). White
represents highest value.
(F) The graph represents apparent FRET (Ea =
D2-D1/D2 3 100%) for different regions of the
T cell. Lines indicate comparisons, and numbers
are p values for comparisons of sample means
by ANOVA.
Immunity
TSG101 in the Immunological Synapsedequenching after acceptor photo-bleaching, with GFP-tagged
proteins as donors and the membrane dye DiI as acceptors
(McLean et al., 2000). In order to use this method to probe
membrane interactions of TSG101, we stably expressed
amurine TSG101-GFP chimera in AND T cells by retroviral trans-
duction and sorted them for uniform expression. We then briefly
labeled transduced T cells with DiI before allowing them to form
conjugates with MCC-loaded murine B cells. Changes in donor
fluorescence after photobleaching of DiI revealed a low and
diffuse FRET signal throughout the T cell, indicating loose
coupling of TSG101 with plasma membrane and endomem-
branes in the steady state (Figures 2E and 2F) as previously
reported (Welsch et al., 2006). Upon IS formation with antigen-
pulsed B cells, TSG101 underwent a marked redistribution,
polarizing strongly to the IS but also outside the IS (Figures 2E
and 2F). The high apparent FRET efficiencies observed is consis-
tent with direct apposition of membranes and tagged TSG101.534 Immunity 32, 531–540, April 23, 2010 ª2010 Elsevier Inc.Notably, the FRET signal was most prominent at the cSMAC in
the T-B cell contacts (Figure 2E). Therefore, T cell activation
results in redistribution of TSG101 to membrane compartments
concentrated in the IS.
Sorting of TCR MCs into the IS Center Depends
on Ub Recognition by TSG101
We then sought to confirm the specificity of TSG101 in inducing
cSMAC formation and signal termination. We observed similar
defects in cSMAC formation and dephosphorylation when
TSG101 was suppressed with three different siRNA oligomers
(Figures S3A and S3C). Restoration of wild-type IS patterning
by reintroduction of wild-type human TSG101 after KD of endog-
enous mouse TSG101 indicated that our observed defects in
TCR dephosphorylation and cSMAC formation were specifically
attributable to TSG101 function (Figures S3A–S3C). However, a
mutant TSG101 with substitutions in the UEV domain that
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Figure 3. Sorting of TCR into the IS Center
Depends on Ubiquitin Recognition by
TSG101
Control or TSG101 KD T cells were rescued by
infection with retroviral siRNA-resistant constructs
containing either wild-type human TSG101 or a
construct containing mutations in the UEV domain
that abrogates ubiquitin recognition (N45A D46A)
(Pornillos et al., 2002). Human TSG101 shares
94.6% amino-acid sequence homology with its
murine ortholog.
(A) Shown are T cells transfected with the indi-
cated siRNA (blue) and re-expression vectors
forming IS on glass-supported planar bilayers con-
taining 2molec/mm2 I-Ek-MCC and 200molec/mm2
ICAM-1. Cells were incubated on bilayers for
30 min, fixed, and stained for TCR and pY. Rescue
vectors are indicated as wild-type (TSG101) or
ubiquitin-binding mutant (TSG-mut).
(B) Synapses were categorized by cSMAC mor-
phology based on central accumulation and phos-
photyrosine enrichment.
(C and D) Bar graphs depict quantification in
arbitrary units (AU) of mean fluorescence at cell-
contact interfaces and represent >100 cells across
two or more experiments with standard errors
shown.
Immunity
TSG101 in the Immunological Synapseabrogate Ub binding (Pornillos et al., 2002) was completely
unable to restore cSMAC formation or dephosphorylation after
TSG101 KD (Figure 3). Cell lysates from TSG101 KD T cells
demonstrated a marked accumulation of ubiquitinated species
as compared to control siRNA-treated T cells (Figure S3D),
and ubiquitination was further increased by agonist MHCp stim-
ulation. These higher-molecular-weight species were also iden-
tifiable by antibodies to CD3z (Figure S3E). This suggests that
CD3z may be a ubiquitinated protein recognized by TSG101. In
combination with the equivalent defects observed in TSG101
KD and MG132-treated T cells forming ISs, these data support
the model that TSG101 specifically interacts with ubiquitinated
components of TCR MCs to induce cSMAC formation and
TCR signal termination.
Differential Sorting of Receptors by TSG101
Numerous receptors are engagedwithin the IS that are regulated
by diverse mechanisms. A recent example of sorting of such
receptors in the IS is the observation that CD28 and TCR traffic
together in peripheral MCs upon engagement and are then
segregated from each other in the cSMAC (Yokosuka et al.,
2008). In light of our finding that Ub-mediated TSG101 recogni-
tion is necessary for its incorporation of TCR into a cSMAC, we
wondered whether TSG101 might also be involved in segre-
gating TCR from CD28. We evaluated these sorting events by
observing control and TSG101 KD T cells interacting with
bilayers containing MHCp, ICAM-1, and CD80 and following
PKC-q enriched compartments. Consistent with prior reports,
we found that in control cells, PKCq, and TCRs colocalized in
peripheral MCs but became segregated in the cSMAC
(Figure 4A and Figure S5A) (Yokosuka et al., 2008). In TSG101KD T cells, however, PKC-q and TCR failed to segregate and
remained colocalized in large MCs in the pSMAC region, with a
significantly elevated Pearson’s correlation coefficient (Figure 4A
and Figure S4A). Therefore, TSG101 functions at the cSMAC-
pSMAC interface to generate distinct TCR- and PKC-q-enriched
domains of the cSMAC.
We then investigated the mechanism by which TSG101 selec-
tively terminates TCRMC signals at the IS center. Normally, TCR
MCs become relatively immobile as they accumulate at the IS
center (Varma et al., 2006). The association of immobile central
TCR with lysobisphosphatidic acid (LBPA) staining is consistent
with incorporation of TCR into MVBs (Varma et al., 2006). In
control T cells, TCR MCs became immobilized as they became
colocalized with LBPA+ structures at the cSMAC (Figures 4B
and 4C). In contrast, we observed continued jostling movements
of large TCR MCs in the periphery of TSG101 KD IS (Figure 4B
and Movie S3). This jostling movement is represented in
Figure 4B by overlaying three sequential images at 2 min inter-
vals with red, green, and blue coding such that immobile
structures appear white and mobile structures appear colored.
The continued jostling of TCR in TSG101 KD IS correlated with
a striking segregation of TCR from LBPA+ structures (Figure 4C).
This segregation was confirmed by a significant decrease in the
Pearson’s correlation coefficient between TCR and LBPA in
TSG101 KD IS (Figure S4B). Thus, TSG101 is required for TCR
colocalization with LBPA+ compartments.
TSG101 Suppression Leads to Chronic TCR Signaling
The striking persistence of phosphorylated TCR MCs after
TSG101 KD (Figures 1G and 1H) suggested to us that the dura-
tion of signaling through engaged TCR might be extendedImmunity 32, 531–540, April 23, 2010 ª2010 Elsevier Inc. 535
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Figure 4. TSG101 Controls Sorting within Plasma Membrane
and Endosomal Compartments
(A) Control and TSG101 KD T cells were incubated on glass-supported planar
bilayers containing 10 molec/mm2 I-Ek-MCC, 100 molec/mm2 CD80, and
200 molec/mm2 ICAM-1 for 30 min, fixed, and stained for TCR and PKCq.
Images display representative distribution of TCR and PKCq in control and
TSG101 KD synapses.
(B) Control and TSG101 KD T cells were incubated on glass-supported planar
bilayers containing 2 molec/mm2 I-Ek-MCC and 200 molec/mm2 ICAM-1 and
allowed to form contacts for 20 min at 37C. They were then imaged by TIRFM
in the presence of fluorescent anti-TCR Fab. White regions indicate immobili-
zation (overlap of red, green, and blue), whereas any individual color (red
green, or blue) indicates movement.
(C) Control and TSG101 KD T cells were incubated on glass-supported planar
bilayers containing I-Ek-MCC and ICAM-1 for 30 min at 37C, fixed, and
stained for TCR and LBPA. Images show representative distribution of TCR
and LBPA in control and TSG101 KD synapses. All images are representative
of >100 cells from at least two experiments.
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Figure 5. TSG101 Suppression Leads to Chronic TCR Signaling
(A) Single-cell intracellular calcium measurements were performed on Fura-2
loaded (A) control (n = 91) and (B) TSG101 KD (n = 57) T cells after
incubation on glass-supported planar bilayers containing 2 molec/mm2
I-Ek-MCC and 200 molec/mm2 ICAM-1 for 10 min at 37C. Cells were then
treated with saturating concentrations (30 mg/mL) of anti-MHC blocking anti-
bodies. Each track depicts individual cell intracellular calcium signal presented
as a ratio of fluorescence at 510 nm when excited at 340/380 nm.
(B) Persistent calcium elevation after anti-MHC block was determined as
follows: Normally, anti-MHC treatment eliminates elevated Ca2+ levels within
2 min. Cells were scored as positive for persistent signaling if intracellular
Ca2+ levels were 50% above baseline calcium levels for at least 3 min after
treatment. Baseline Ca2+ values were determined by imaging cells on bilayers
containing ICAM-1 alone.
(C) Control and TSG101 KD T cells were loaded with an IL2 capture reagent
(Miltenyi) and then incubated on glass-supported planar bilayers containing
2 molec/mm2 I-Ek-MCC and 200 molec/mm2 ICAM-1 for 6 hr. Cells were fixed,
stained with fluorescent IL2-PE antibodies, and imaged for total PE fluores-
cence. Bar graphs depict quantification of total IL2 fluorescence per cell in
arbitrary units (AUs) and represent >100 cells across three experiments with
standard errors.
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TSG101 in the Immunological Synapsein TSG101 KD T cells. To test this, we allowed control and
TSG101 KD T cells to be activated with agonist MHCp ligand
on bilayers for 10 min, sufficient to induce stable TCR engage-
ments, prior to treatment with blocking I-Ek-MCC antibodies
(D4) to prevent new TCRMC formation. Signaling wasmonitored
with intracellular Ca2+. In control siRNA-treated T cells, the Ca2+
signal decayed over 2 min (Figures 5A and 5B and Figure S5), as
previously described (Varma et al., 2006). In contrast, Ca2+
elevation decayed only partially and was then sustained at an
intermediate level in TSG101 KD T cells after D4 treatment
(Figures 5A and 5B and Figure S5). The net effect of increased
TCR signaling in TSG101 KD T cells was increased IL-2 produc-
tion compared to control siRNA-treated T cells (Figure 5C). It was
not possible to examine proliferation of T cells in the TSG101 KD
because TSG101 is required for the abscission step of cellular536 Immunity 32, 531–540, April 23, 2010 ª2010 Elsevier Inc.cytokinesis (Morita et al., 2007); as such, we noted that
TSG101 KD consistently inhibited T cell proliferation. Thus,
TSG101 plays an important role in limiting downstream T cell
signals and effector responses after productive proximal
signaling in response to TCR engagement.Weak Agonist MHCp Do Not Involve TSG101
Typical recognition of agonist pMHC results in both tyrosine
phosphorylation-mediated T cell activation and Ub-mediated
TCR downregulation (Naramura et al., 2002; Samelson et al.,
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Figure 6. Low-Avidity Ligands Signal
through Microclusters but Avoid ESCRT-
Mediated TCR Downregulation
(A) ANDTcellswere incubated on glass-supported
planar bilayers containing 200molec/mm2 ICAM-1,
100 molec/mm2 CD80, and 10 molec/mm2
I-Ek-MCC or I-Ek-K99A as indicated and immedi-
ately and imagedbyTIRFMat 37C in thepresence
of fluorescent anti-TCR Fab. Yellow circles indi-
cate tracks of individual TCRMCs. Bar graph (right)
depicts quantification in arbitrary units (AU) of
mean TCR fluorescence at cell-contact interfaces
in ISs formed by AND T cells in response to
ICAM-1, ICAM-1 + I-Ek-K99A, or ICAM-1 +
I-Ek-MCC and represent >100 cells across two or
more experiments with standard errors.
(B) ANDTcellswere incubatedon glass-supported
planar bilayers containing 200molec/mm2 ICAM-1,
100 molec/mm2 CD80, and 10 molec/mm2
I-Ek-MCC or I-Ek-K99A as indicated for 30 min at
37C, fixed, and stained for TCR and TSG101.
Images show representative distribution of
TCR and TSG101 in IS formed in response to
I-Ek-MCC or I-Ek-K99A.
(C) Control and TSG101 KD T cells were incubated
on glass-supported planar bilayers containing
200 molec/mm2 ICAM-1, 100 molec/mm2 CD80,
and 10 molec/mm2 I-Ek-MCC or I-Ek-K99A as indi-
cated for 30 min at 37C, fixed, and stained for
TCRandpY.Bargraphsdepictquantification inarbi-
trary units (AU) of mean pY fluorescence at cell-
contact interfaces, and represent >100 cells across
two or more experiments with standard errors.
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TSG101 in the Immunological Synapse1986). However, T cell activation in the absence of TCR downre-
gulation has recently been reported. The altered peptide ligand
(APL) MCC-K99A, a variant of MCC88-103 with a single amino
acid substitution that greatly accelerates I-Ek-based tetramer
dissociation compared to the native sequence, effectively stim-
ulates proliferation of AND Tg T cells when presented by splenic
APCs despite inducing diminished TCR downregulation and
central TCR accumulation (Cemerski et al., 2007). We began
investigating IS formation by AND T cells in response to
I-Ek-MCC-K99A in a planar bilayer system to understand the
properties of this ligand-receptor interaction. Supported planar
bilayers presenting I-Ek-MCC-K99A and ICAM-1 arrested
T cell migration and induced sustained Ca2+ elevation in AND
T cells only in the presence of CD80 (Figures S6A and S6B).
This is consistent with reports in which CD28 engagement is
required for response to weak agonist ligands (Bachmann
et al., 1997). Real-time imaging of TCR and LFA-1-ICAM-1 inter-
actions demonstrated that, in the presence of CD80, T cells re-
sponding to I-Ek-MCC-K99A formed ISs with many structural
similarities to I-Ek-MCC-induced ISs. T cells spread symmetri-
cally on K99A-presenting surfaces, and LFA-1-ICAM-1 interac-
tions quickly organized into a pSMAC (Figure S6C). Tyrosine
phosphorylation and proximal TCR signaling (indicated by
recruitment and phosphorylation of LAT) were concentrated in
small MCs in the periphery of the IS with a similar intensity
and frequency to IS formed in response to I-Ek-MCC (Figures
S6C and S6D). However, in striking contrast to I-Ek-MCC-
induced ISs, TCR did not accumulate in the IS center even in
response to 10 molecules/mm2 of I-Ek-MCC-K99A (Figures 6Aand 6B, p < 0.0001; Figures S6C and S6D). Time-lapse TIRFM
imaging of IS formed in response to I-Ek-MCC-K99A revealed
costimulation dependent formation and centripetal transloca-
tion of TCR MCs (Figure 6A and Movie S4); however, these
MCs dissipated as they reached the center of the IS rather
than accumulating in a cSMAC as they do in response to I-Ek-
MCC.
In order to resolve this difference between I-Ek-MCC-K99A
and I-Ek-MCC-induced ISs, we investigated the contribution of
TSG101 to ISs formed in response to these respective ligands.
Notably, TSG101 was recruited to the cSMAC of I-Ek-MCC-
induced ISs, but not to I-Ek-MCC-K99A-induced ISs (Figure 6B).
Furthermore, TSG101 KD had no impact on TCR MC formation,
size, transport, or phosphotyrosine levels within MCC-K99A
induced ISs (Figure 6C and Figure S6E). These results demon-
strate that TSG101 is not required for early TCR signaling, TCR
MC transport, pSMAC formation, or a radially symmetric IS
in response to the MCC-K99A weak agonist MHCp. It has
previously been demonstrated that TCR MCs form in an
F-actin-dependent manner, but then become rapidly F-actin
independent on the basis of their stability in the presence of
latrunculin A, which sequesters G-actin (Varma et al., 2006).
Weak agonist MCC-K99A-induced TCR MCs remained F-actin
dependent, in contrast to many F-actin-independent MCs that
accumulation in response to I-Ek-MCC (Figure S6F). The cSMAC
is generally free or depleted of F-actin (Kaizuka et al., 2007).
Analysis of the F-actin distribution in the IS formed in response
to MCC and MCC-K99A MHCp confirmed that I-Ek-MCC-
K99A does not induce an F-actin-free central zone (Figure S6G).Immunity 32, 531–540, April 23, 2010 ª2010 Elsevier Inc. 537
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We previously demonstrated that the cSMAC shows a striking
enrichment of LBPA (Varma et al., 2006), a lipid associated
with MVBs. This suggested that the cSMAC might be a site for
degradation of TCR through an ESCRT-dependent pathway
(Williams and Urbe´, 2007). Other results in the field were consis-
tent with this notion including earlier observations that CD2AP,
an adaptor linking actin and Cbl family ubiquitin E3-ligases is
required for normal TCR degradation and signal termination in
the cSMAC (Lee et al., 2003). There was also ample evidence
for a role of Cbl family E3 ligases in TCR signal termination and
a role for lysosomes in TCR degradation (Liu et al., 2000;
Naramura et al., 2002; Valitutti et al., 1997). It had also been
demonstrated that TCR downregulation correlates with MHCp
potency (Itoh et al., 1999) and that a subset of weak agonist
ligands do not trigger TCR downregulation at all (Cemerski
et al., 2007). Furthermore, the TCR z and d chains are directly
ubiquitinated upon strong TCR engagement (Cenciarelli et al.,
1992). On the basis of these observations, we anticipated that
ubiquitination and ESCRT machinery might be important for
TCR signal termination and eventual degradation after engage-
ment with agonist MHCp. We were surprised by our finding in
this study that depletion of free ubiquitin with MG132 or knock-
down of TSG101 not only blocked TCR signal termination and
degradation but also blocked cSMAC formation in response to
agonist MHCp. In contrast, a weak agonist MHCp could induce
robust TCR MCs, Ca2+ elevation, and pSMAC formation without
recruiting TSG101 or inducing a cSMAC in normal T cells. These
results have important implications for signal integration in
response to agonist MHCp and how this differs from weak
agonist MHCp.
Our results suggest distinct roles for major Ub-recognizing
ESCRT components HRS and TSG101 in IS formation and
TCR downregulation. HRS is part of ESCRT-0 and associates
with ubiquitinated cargo through its ubiquitin interaction motif
(UIM) (Bache et al., 2003b; Hirano et al., 2006), in parallel with
inositol-3-phosphate-bearing lipids present in endosomes
(Raiborg et al., 2001). In EGFR systems, HRS promotes ubiquitin
recognition by TSG101 by directing TSG101 to early endosomes
containing ubiquitinated cargo (Katzmann et al., 2003). This
process is dependent on the recruitment of HRS recruitment
to receptors within clathrin lattices (Raiborg et al., 2002), and
clathrin clustering of ubiquitinated cargo is required for efficient
HRS recognition (Raiborg et al., 2006). Indeed, in EGF-R sys-
tems involving both clathrin-dependent and clathrin-indepen-
dent endocyticmechanisms, HRS is involved only in degradation
of clathrin-endocytosed receptors (Myromslien et al., 2006). The
specificity of HRS for clathrin-coated pits and the failure of TCR
MCs to intersect with these compartments may explain the
finding that a cSMAC is formed in the absence of HRS (Razi
and Futter, 2006). Furthermore, in non-EGFR systems, the
association of HRS and TSG101 is not so clear. Indeed,
TSG101-mediated endosomal trafficking of Tyrp1 is indepen-
dent of HRS function in melanocytes (Truschel et al., 2009).
Furthermore, HRS is involved in alternate internal trafficking
pathways, such as sequence-dependent recycling of the
beta-2 adrenergic receptor (Hanyaloglu et al., 2005). Thus, prior
models suggesting a strictly sequential transfer of ubiquitinated538 Immunity 32, 531–540, April 23, 2010 ª2010 Elsevier Inc.cargo from ESCRT-0 to ESCRT-I may not apply in all situations,
as has been recently demonstrated (Shields et al., 2009). Down-
regulation of engaged TCR complexes appears to be clathrin
independent (Monjas et al., 2004), whereas internalization of
the proximal signaling molecule LAT has been shown to be
clathrin dependent (Brignatz et al., 2005). We detected a weak
but significant effect of HRS KD on non-TCR MC-associated
phosphotyrosine. This suggests that HRS may act on distinct
substrates from the TCR during T cell activation and this is
worthy of further study.
Our results provide insight into the distinct mechanisms of
sustained signaling by agonist and weak agonist MHCp.
TSG101 prevents chronic signaling by agonist MHCp induced
TCR MCs. TCR-agonist MHCp and CD28-CD80 interactions
are initially colocalized in MCs, but then are segregated within
the cSMAC (Yokosuka et al., 2008). We show that this segrega-
tion requires TSG101. There are a number of possibilities for how
TSG101 organizes this process. Two possibilities are polymeri-
zation of ESCRT III components to generate MVBs that are
then translocated toward the center by microtubules (Wollert
et al., 2009) or linkage to a final actin-dependent translocation
step through Alix before later ESCRT steps are initiated (Pan
et al., 2006; Strack et al., 2003). This sorting process, however
mediated, led to formation of the PKC-q-rich compartment,
which is a hallmark of the IS formed with professional APCs
(Monks et al., 1997; Tseng et al., 2008; Yokosuka et al., 2008).
Weak agoinst MHCp required CD80 in the bilayer to form TCR
MCs and sustain Ca2+ signals, which is not the case for agonist
MHCp. This result is consistent with earlier studies showing that
responses to weak agoinst MHCp are CD28 dependent (Bach-
mann et al., 1997). Weak agonist MCC-K99A induced TCR
MCs that remained F-actin dependent and disappeared in the
center of the IS without a requirement for an F-actin free central
zone or TSG101. The mechanism by which weak agonist MHCp
signals are terminated is not clear, but we speculate that the
requirement for a dynamic contribution from CD80 and the
continued requirement for F-actin may enable physical disen-
gagement and recycling of TCR at the point of convergence of
centripetal F-actin flow (Kaizuka et al., 2007). More stable MCs
formed by agonist MHCp might persist in response to the
same physical process, necessitating the use of TSG101 to
mark irreversibly clustered TCR-MHCp complex for elimination.
The other distinguishing feature of signaling mediated by agonist
and weak agonist MHCp is the generation of the consolidated
PKC-q-rich compartment by agonist MHCp. Given that the
cSMAC size is linearly related to agonist MHCp density (Varma
et al., 2006), the formation of the PKC-q-rich outer cSMAC
may provide a mechanism to measure integrated TCR avidity
in an IS as long as CD80 or CD86 are present on the APC.
These data lead us to a model in which ESCRT-I is required for
sorting of TCR into MVB-like structures within the cSMAC and
for signal termination in response to agonist MHCp. TCR and
CD28 engagements occur primarily in the IS dSMAC, resulting
in receptor phosphorylation, actin-driven centripetal movement
of microclusters, and ubiquitination of TCRs but not CD28
complexes. Upon reaching the border between the pSMAC
and cSMAC, TSG101 specifically sorts strong agonist-engaged
ubiquitinated TCR into central MVB or lysosomal compartments,
leaving CD28 along with associated PKCq to accumulate and
Immunity
TSG101 in the Immunological Synapsecontinue signaling from an annular cluster. Weak agonist-
engaged TCR clusters are not subject to TSG101-mediated sort-
ing and are thus not incorporated into the cSMAC. Our findings
clarify the mechanism of cSMAC formation and the origin of
recently described segregation of inner TCR and outer,
PKC-q-enriched, cSMAC regions (Kaizuka et al., 2007; Varma
et al., 2006; Yokosuka et al., 2008). Integrating TSG101 into
our current picture of IS structure clarifies the inhibitory role of
the cSMAC and the sorting function of TSG101 reconciles the
coexistence of signaling and degradation compartments within
this central structure in T cell activation (Cemerski et al., 2008;
Lee et al., 2003; Varma et al., 2006).
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